NCT01281371

Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without Sitaxentan

Clinical Devolution of a Medication Change at Patients With Mono- or Combination Therapy With Sitaxentan to a Regime Without Sitaxentan.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 9 (actual)
• Sponsor: Heidelberg University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Due to the withdrawal of Thelin (Sitaxentan) in December 2010 all patients with pulmonary hypertension treated with Sitaxentan need to be switched to an alternative therapy. This study will observe in which way the change of medication - in the clinical routine, without exception in charge of the treating physician - affects clinical and laboratory parameters and patient's quality of life.

Conditions

• Hypertension, Pulmonary

Timeline

• Start date: 2011-01-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2011-01-21
• Last updated: 2013-06-27

Locations

1 site across 1 country: Germany